Efferon LPS Now Available in Italy – Efferon

01 July 2025

Efferon LPS Now Available in Italy

We are pleased to announce that as of July, residents of Italy now have access to the Efferon LPS hemoadsorption device. Our esteemed partner in Italy is Gada Italia, a company of the Palex Group. Gada Italia is a national leader in the distribution of high-value medical technologies, boasting over 40 years of experience in medical device distribution throughout Italy and collaborating with more than 500 hospitals and clinics.

Efferon is a next-generation hemoadsorption cartridge engineered to remove both endotoxins and cytokines from the bloodstream. It has received EU approval for use in sepsis patients under the MDR regulation.

Benvenuti, Gada Italia

01 July 2025

Efferon LPS Now Available in Italy

28 June 2025

Applying Vicenza’s Lessons

23 June 2025

Efferon Expands Its Global Presence

Critical Care 2024, 28(Suppl 1):P220

Hemoperfusion with Efferon LPS NEO device reverts multiple organ failure, decreases IL-6 and TNF levels and systemic immune inflammation in children with sepsis

Shock. 2023 Jun 1;59(6):846-854

Hemoperfusion using the LPS-selective mesoporous polymeric adsorbent in septic shock: a multicenter randomized clinical trial

Intensive Care Medicine Experimental 2022, 10(2): 000710

Extracorporeal hemoperfusion with Efferon LPS for rapid reconstitution of vital parameters and decreasing proinflammatory biomarkers in patients with intra-abdominal sepsis

World Journal of Medical Case Reports. Vol. 2, No. 3, 2021, pp. 46-50.

Application of novel device Efferon LPS in hemoperfusion for simultaneous removal of endotoxin and cytokines in a patient with septic shock

Therapeutic archive. 2021; 93 (7): 811-817

Extracorporeal adsorption of cytokines in cytokine release syndrome in a patient with acute lymphoblastic leukemia after therapy with T cells with a chimeric antigen receptor. Clinical observation

General resuscitation. 2020; 16 (6): 31-53.

Application of adsorbent based on a hypercrosslinked styrene-divinylbenzene copolymer with an immobilized LPS-selective ligand in hemoperfusion for the treatment of patients with septic shock

General resuscitation. 2020; 16 (4): 14-20.

Hemosorption carried out by a column filled with hypercrosslinked styrene-divinibenzene copolymer with an immobilized LPS-selective ligand in a complex of intensive treatment of acute lung injury in the surgical treatment of lung cancer (clinical observation)

General resuscitation. 2018; 14 (6): 51-60.

Efficiency and safety of a new product for LPS-selective hemosorption (experimental study)

General resuscitation. 2016; 12 (6): 82-107.

Sorbents for extracorporeal removal of toxic substances and molecules with unwanted biological activity (review)

General resuscitation. 2017; 13 (5): 109-120.

Methods for the determination of bacterial endotoxin in critical care medicine (review).